A Frequent Thrombomodulin Amino Acid Dimorphism Is not Associated with Thrombophilia

Summary

We report a C/T dimorphism in the thrombomodulin (TM) gene that predicts an Ala⁴⁵⁵ → Val replacement in the sixth EGF-like domain of TM. This dimorphism has allelic frequencies of 82 (Ala) and 18% (Val) in a normal population. In a group of protein C deficient patients and in a group of subjects with unexplained thrombophilia the allelic frequencies were found to be the same as in the normal population. This indicates that with respect to thrombophilia the dimorphism is essentially neutral.

• References

• 1 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746
• 2 Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300
• 3 Broekmans AW, Veitkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism. N Engl J Med 1983; 309: 340-344
• 4 Sas G, Blaskó G, Banhegyi D, Jákó J, Palos LA. Abnormal antithrombin III (antithrombin III “BUDAPEST”) as a cause of a familial thrombophilia. Thromb Diath Haemorrh 1974; 32: 105-115
• 5 Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-996
• 6 Imada S, Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 1990; 140: 113-122
• 7 Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD. Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 1987; 84: 6425-6429
• 8 Suzuki K, Kusumoto H, Deyashiki Y, Nishioko J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a co-factor for protein C activation. EMBO J 1987; 6: 1891-1897
• 9 Engesser L. Thrombophilia: Disorders of blood coagulation and fibrinolysis. Thesis, Leiden 1988
• 10 Reitsma Ph, te Lintel Hekkert W, Koenhen E, van der Velden PA, Allaart CF, Deutz-Terlouw PP, Poort SR, Bertina RM. Application of two neutral MspI DNA polymorphisms in the analysis of hereditary protein C deficiency. Thromb Hemostas 1990; 64: 239-244
• 11 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Ehrlich HA. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 1988; 239: 487-489
• 12 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitions. Proc Natl Acad Sci USA 1977; 74: 5463-5467
• 13 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-507
• 14 Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw PP, van der Linden JK, Reitsma PH. The Heerlen dimorphism of protein S, an immunologic dimorphism due to dimorphism of residue 460. Blood 1990; 76: 538-548
• 15 Wallmark A, Ljung R, Nillson IM, Holmberg L, Hedner U, Lindvall M, Sjogren HO. Polymorphism of normal factor IX detected by mouse monoclonal antibodies. Proc Natl Acad Sci USA 1985; 82: 3839-3843